# Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease

> **NCT01094613** · PHASE1,PHASE2 · TERMINATED · sponsor: **Teva GTC** · enrollment: 70 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Delayed Release 6 mercaptopurine
- **DRUG:** 6 Mercaptopurine

## Key facts

- **NCT ID:** NCT01094613
- **Lead sponsor:** Teva GTC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 70 (ACTUAL)
- **Why stopped:** Sponsor withdrew support of study due to reorganization and project prioritization
- **Last updated:** 2013-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01094613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01094613, "Multicenter Clinical Efficacy and Safety Study of Delayed Release 6MP in Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01094613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*